Article
The assembly of cancer-specific ribosomes by the lncRNA <i>LISRR</i> suppresses melanoma anti-tumour immunity
2023-01-08
Abstract excerpt
Although immune checkpoint blockade (ICB) has revolutionized cancer treatment, resistance mechanisms limit its clinical benefit. Here we characterise LISRR , a cancer-specific lncRNA highly expressed in melanoma patients refractory to ICB. In cells undergoing (therapeutic) stress, LISRR recruits DAZAP1 (Deleted in AZoospermia Associated Protein 1) to polysomes and drives the assembly of a subset of ribosomes at...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 424c149b-88b1-5ad4-86ff-1928772260c9
- DOI
- 10.1101/2023.01.06.523012
